Y-Intercept (HK)’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-32,359
| Closed | -$176K | – | 1470 |
|
|
2024
Q4 | $176K | Buy |
32,359
+19,713
| +156% | +$107K | 0.01% | 1064 |
|
|
2024
Q3 | $105K | Buy |
+12,646
| New | +$105K | 0.01% | 1209 |
|
|
2024
Q2 | – | Sell |
-99,813
| Closed | -$865K | – | 1728 |
|
|
2024
Q1 | $865K | Buy |
99,813
+42,507
| +74% | +$369K | 0.07% | 445 |
|
|
2023
Q4 | $375K | Buy |
57,306
+33,812
| +144% | +$221K | 0.03% | 735 |
|
|
2023
Q3 | $235K | Buy |
+23,494
| New | +$235K | 0.02% | 859 |
|
|
2023
Q2 | – | Sell |
-50,060
| Closed | -$701K | – | 1556 |
|
|
2023
Q1 | $701K | Sell |
50,060
-3,116
| -6% | -$43.7K | 0.08% | 383 |
|
|
2022
Q4 | $761K | Buy |
+53,176
| New | +$761K | 0.11% | 284 |
|
|
2022
Q3 | – | Sell |
-17,351
| Closed | -$493K | – | 1163 |
|
|
2022
Q2 | $493K | Buy |
17,351
+9,596
| +124% | +$273K | 0.06% | 430 |
|
|
2022
Q1 | $274K | Buy |
+7,755
| New | +$274K | 0.06% | 484 |
|
|
2021
Q4 | – | Sell |
-10,216
| Closed | -$501K | – | 771 |
|
|
2021
Q3 | $501K | Buy |
10,216
+1,786
| +21% | +$87.6K | 0.09% | 331 |
|
|
2021
Q2 | $352K | Buy |
+8,430
| New | +$352K | 0.09% | 361 |
|